Understanding the treatment preferences of people with relapsing remitting multiple sclerosis

被引：0
|
作者：
Ford, H. [1 ]
Manzano, A. [2 ]
Eskyte, I. [2 ]
Pavitt, S. [2 ]
Pepper, G. [3 ]
Schmierer, K.
Chataway, J. [4 ]
Potrata, B. [5 ]
Webb, E. [2 ]
Meads, D. [2 ]
Marti, J. [6 ]
Bekker, H. [2 ]
机构：
[1] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England
[2] Univ Leeds, Leeds, W Yorkshire, England
[3] Shift Ms, Leeds, W Yorkshire, England
[4] UCL, London, England
[5] Gallup, London, England
[6] Imperial Coll London, London, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1746
引用
收藏
页码：919 / 920
页数：2
相关论文
共 50 条
  • [1] Treatment of relapsing remitting multiple sclerosis
    Lubetzki, C
    REVUE NEUROLOGIQUE, 2001, 157 (8-9) : 996 - 1000
  • [2] Understanding treatment decisions from the perspective of people with relapsing remitting multiple Sclerosis: A critical interpretive synthesis
    Eskyte, Ieva
    Manzano, Ana
    Pepper, George
    Pavitt, Sue
    Ford, Helen
    Bekker, Hilary
    Chataway, Jeremy
    Schmierer, Klaus
    Meads, David
    Webb, Edward
    Potrata, Barbara
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 27 : 370 - 377
  • [3] Ozanimod for the treatment of relapsing remitting multiple sclerosis
    Rasche, Ludwig
    Paul, Friedemann
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (18) : 2073 - 2086
  • [4] Laquinimod in the treatment of relapsing remitting multiple sclerosis
    Hainke, Undine
    Thomas, Katja
    Ziemssen, Tjalf
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (06) : 701 - 709
  • [5] Daclizumab for the treatment of relapsing-remitting multiple sclerosis
    Herwerth, Marina
    Hemmer, Bernhard
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (06) : 747 - 753
  • [6] Fingolimod hydrochloride for the treatment of relapsing remitting multiple sclerosis
    Thomas, Katja
    Proschmann, Undine
    Ziemssen, Tjalf
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (15) : 1649 - 1660
  • [7] Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
    Menge, Til
    Dubey, Divyanshu
    Warnke, Clemens
    Hartung, Hans-Peter
    Stuve, Olaf
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (10) : 1131 - 1139
  • [8] Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis
    Hersh, Carrie M.
    Cohen, Jeffrey A.
    IMMUNOTHERAPY, 2014, 6 (03) : 249 - 259
  • [9] Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis
    Fox, Edward J.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (12) : 1789 - 1797
  • [10] Guiding Treatment Deescalation in Relapsing Remitting Multiple Sclerosis
    Mueller, Jannis
    Sharmin, Sifat
    Lorscheider, Johannes
    Horakova, Dana
    Havrdova, Eva
    Izquierdo Ayuso, Guillermo
    Eichau Madueno, Sara
    Patti, Francesco
    Grammond, Pierre
    Buzzard, Katherine
    Skibina, Olga
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Grand'Maison, Francois
    Alroughani, Raed
    Lechner-Scott, Jeannette
    Spitaleri, Daniele L. A.
    Barnett, Michael
    Cartechini, Elisabetta
    Sa, Maria Jose
    Gerlach, O.
    van der Walt, Anneke
    Butzkueven, Helmut
    Prevost, Julie
    Castillo-Trivino, Tamara
    Yamout, Bassem I.
    Khoury, Samia
    Yaldizli, Ozgur
    Derfuss, Tobias
    Granziera, Cristina
    Kuhle, Jens
    Kappos, Ludwig
    Roos, Izanne
    Kalincik, Tomas
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 105 - 107
12345